Keywords
Last Name
Institution

SUE-HWA LIN

TitleProfessor
InstitutionMD Anderson
DepartmentTranslational Molecular Pathology
Address1515 Holcombe Blvd
Houston TX 77030-4009
vCardDownload vCard

    Collapse Additional Tools and Researcher Information 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Yu G, Cheng CJ, Lin SC, Lee YC, Frigo DE, Yu-Lee LY, Gallick GE, Titus MA, Nutt LK, Lin SH. Organelle-derived acetyl-CoA promotes prostate cancer cell survival, migration, and metastasis via activation of calmodulin kinase II. Cancer Res. 2018 Mar 13. PMID: 29535221.
      View in: PubMed
    2. Yu-Lee LY, Yu G, Lee YC, Lin SC, Pan J, Pan T, Yu KJ, Liu B, Creighton CJ, Rodriguez-Canales J, Villalobos PA, Wistuba II, de Nadal E, Posas F, Gallick GE, Lin SH. Osteoblast-secreted factors mediate dormancy of metastatic prostate cancer in the bone via activation of the TGFßRIII-p38MAPK-pS249/T252RB pathway. Cancer Res. 2018 Mar 07. PMID: 29514796.
      View in: PubMed
    3. Pan T, Lin SC, Yu KJ, Yu G, Song JH, Lewis VO, Bird JE, Moon B, Lin PP, Tannir NM, Jonasch E, Wood CG, Gallick GE, Yu-Lee LY, Lin SH, Satcher RL. BIGH3 Promotes Osteolytic Lesions in Renal Cell Carcinoma Bone Metastasis by Inhibiting Osteoblast Differentiation. Neoplasia. 2018 Jan; 20(1):32-43. PMID: 29190493.
      View in: PubMed
    4. Lin SC, Lee YC, Yu G, Cheng CJ, Zhou X, Chu K, Murshed M, Le NT, Baseler L, Abe JI, Fujiwara K, deCrombrugghe B, Logothetis CJ, Gallick GE, Yu-Lee LY, Maity SN, Lin SH. Endothelial-to-Osteoblast Conversion Generates Osteoblastic Metastasis of Prostate Cancer. Dev Cell. 2017 Jun 05; 41(5):467-480.e3. PMID: 28586644.
      View in: PubMed
    5. Chen J, Raju GS, Jogunoori W, Menon V, Majumdar A, Chen JS, Gi YJ, Jeong YS, Phan L, Belkin M, Gu S, Kundra S, Mistry NA, Zhang J, Su X, Li S, Lin SH, Javle M, McMurray JS, Rahlfs TF, Mishra B, White J, Rashid A, Beauchemin N, Weston BR, Shafi MA, Stroehlein JR, Davila M, Akbani R, Weinstein JN, Wu X, Mishra L. Mutational Profiles Reveal an Aberrant TGF-?-CEA Regulated Pathway in Colon Adenomas. PLoS One. 2016; 11(4):e0153933. PMID: 27100181; PMCID: PMC4839765.
    6. Weiderhold KN, Fadri-Moskwik M, Pan J, Nishino M, Chuang C, Deeraksa A, Lin SH, Yu-Lee LY. Dynamic Phosphorylation of NudC by Aurora B in Cytokinesis. PLoS One. 2016; 11(4):e0153455. PMID: 27074040; PMCID: PMC4830538.
    7. Tu SM, Bilen MA, Hess KR, Broaddus RR, Kopetz S, Wei C, Pagliaro LC, Karam JA, Ward JF, Wood CG, Rao P, Tu ZH, General R, Chen AH, Nieto YL, Yeung SC, Lin SH, Logothetis CJ, Pisters LL. Intratumoral heterogeneity: Role of differentiation in a potentially lethal phenotype of testicular cancer. Cancer. 2016 Jun 15; 122(12):1836-43. PMID: 27018785.
      View in: PubMed
    8. Lee YC, Lin SC, Yu G, Cheng CJ, Liu B, Liu HC, Hawke DH, Parikh NU, Varkaris A, Corn P, Logothetis C, Satcher RL, Yu-Lee LY, Gallick GE, Lin SH. Identification of Bone-Derived Factors Conferring De Novo Therapeutic Resistance in Metastatic Prostate Cancer. Cancer Res. 2015 Nov 15; 75(22):4949-59. PMID: 26530902.
      View in: PubMed
    9. Satcher RL, Pan T, Bilen MA, Li X, Lee YC, Ortiz A, Kowalczyk AP, Yu-Lee LY, Lin SH. Cadherin-11 endocytosis through binding to clathrin promotes cadherin-11-mediated migration in prostate cancer cells. J Cell Sci. 2015 Dec 15; 128(24):4629-41. PMID: 26519476.
      View in: PubMed
    10. Varkaris A, Corn PG, Parikh NU, Efstathiou E, Song JH, Lee YC, Aparicio A, Hoang AG, Gaur S, Thorpe L, Maity SN, Bar Eli M, Czerniak BA, Shao Y, Alauddin M, Lin SH, Logothetis CJ, Gallick GE. Integrating Murine and Clinical Trials with Cabozantinib to Understand Roles of MET and VEGFR2 as Targets for Growth Inhibition of Prostate Cancer. Clin Cancer Res. 2016 Jan 1; 22(1):107-21. PMID: 26272062.
      View in: PubMed
    11. Pan T, Fong EL, Martinez M, Harrington DA, Lin SH, Farach-Carson MC, Satcher RL. Three-dimensional (3D) culture of bone-derived human 786-O renal cell carcinoma retains relevant clinical characteristics of bone metastases. Cancer Lett. 2015 Aug 28; 365(1):89-95. PMID: 26004343.
      View in: PubMed
    12. Chatterji T, Varkaris AS, Parikh NU, Song JH, Cheng CJ, Schweppe RE, Alexander S, Davis JW, Troncoso P, Friedl P, Kuang J, Lin SH, Gallick GE. Yes-mediated phosphorylation of focal adhesion kinase at tyrosine 861 increases metastatic potential of prostate cancer cells. Oncotarget. 2015 Apr 30; 6(12):10175-94. PMID: 25868388.
      View in: PubMed
    13. Li TH, Chang CC, Cheng IJ, Lin SC. Development of a Summarized Health Index (SHI) for use in predicting survival in sea turtles. PLoS One. 2015; 10(3):e0120796. PMID: 25803431.
      View in: PubMed
    14. Bilen MA, Lin SH, Tang DG, Parikh K, Lee MH, Yeung SC, Tu SM. Maintenance Therapy Containing Metformin and/or Zyflamend for Advanced Prostate Cancer: A Case Series. Case Rep Oncol Med. 2015; 2015:471861. PMID: 25861496.
      View in: PubMed
    15. Mandelin J, Cardó-Vila M, Driessen WH, Mathew P, Navone NM, Lin SH, Logothetis CJ, Rietz AC, Dobroff AS, Proneth B, Sidman RL, Pasqualini R, Arap W. Selection and identification of ligand peptides targeting a model of castrate-resistant osteogenic prostate cancer and their receptors. Proc Natl Acad Sci U S A. 2015 Mar 24; 112(12):3776-81. PMID: 25762070.
      View in: PubMed
    16. Lee YC, Gajdosik MS, Josic D, Clifton JG, Logothetis C, Yu-Lee LY, Gallick GE, Maity SN, Lin SH. Secretome analysis of an osteogenic prostate tumor identifies complex signaling networks mediating cross-talk of cancer and stromal cells within the tumor microenvironment. Mol Cell Proteomics. 2015 Mar; 14(3):471-83. PMID: 25527621; PMCID: PMC4349970.
    17. Ortiz A, Lee YC, Yu G, Liu HC, Lin SC, Bilen MA, Cho H, Yu-Lee LY, Lin SH. Angiomotin is a novel component of cadherin-11/?-catenin/p120 complex and is critical for cadherin-11-mediated cell migration. FASEB J. 2015 Mar; 29(3):1080-91. PMID: 25466890; PMCID: PMC4422367.
    18. Mitani Y, Rao PH, Maity SN, Lee YC, Ferrarotto R, Post JC, Licitra L, Lippman SM, Kies MS, Weber RS, Caulin C, Lin SH, El-Naggar AK. Alterations associated with androgen receptor gene activation in salivary duct carcinoma of both sexes: potential therapeutic ramifications. Clin Cancer Res. 2014 Dec 15; 20(24):6570-81. PMID: 25316813; PMCID: PMC4268116.
    19. Bilen MA, Reyes A, Bhowmick D, Maa A, Bast R, Pisters LL, Lin SH, Logothetis CJ, Tu SM. Variant prostate carcinoma and elevated serum CA-125. Can J Urol. 2014 Oct; 21(5):7442-8. PMID: 25347368.
      View in: PubMed
    20. Satcher RL, Pan T, Cheng CJ, Lee YC, Lin SC, Yu G, Li X, Hoang AG, Tamboli P, Jonasch E, Gallick GE, Lin SH. Cadherin-11 in renal cell carcinoma bone metastasis. PLoS One. 2014; 9(2):e89880. PMID: 24587095.
      View in: PubMed
    21. McCoy F, Darbandi R, Lee HC, Bharatham K, Moldoveanu T, Grace CR, Dodd K, Lin W, Chen SI, Tangallapally RP, Kurokawa M, Lee RE, Shelat AA, Chen T, Green DR, Harris RA, Lin SH, Fissore RA, Colbran RJ, Nutt LK. Metabolic activation of CaMKII by coenzyme A. Mol Cell. 2013 Nov 7; 52(3):325-39. PMID: 24095281.
      View in: PubMed
    22. Chuang C, Pan J, Hawke DH, Lin SH, Yu-Lee LY. NudC deacetylation regulates mitotic progression. PLoS One. 2013; 8(9):e73841. PMID: 24069238; PMCID: PMC3777959.
    23. Lee YC, Bilen MA, Yu G, Lin SC, Huang CF, Ortiz A, Cho H, Song JH, Satcher RL, Kuang J, Gallick GE, Yu-Lee LY, Huang W, Lin SH. Inhibition of cell adhesion by a cadherin-11 antibody thwarts bone metastasis. Mol Cancer Res. 2013 Nov; 11(11):1401-11. PMID: 23913163; PMCID: PMC3834228.
    24. Logothetis CJ, Gallick GE, Maity SN, Kim J, Aparicio A, Efstathiou E, Lin SH. Molecular classification of prostate cancer progression: foundation for marker-driven treatment of prostate cancer. Cancer Discov. 2013 Aug; 3(8):849-61. PMID: 23811619; PMCID: PMC3926428.
    25. Wu CF, Liu S, Lee YC, Wang R, Sun S, Yin F, Bornmann WG, Yu-Lee LY, Gallick GE, Zhang W, Lin SH, Kuang J. RSK promotes G2/M transition through activating phosphorylation of Cdc25A and Cdc25B. Oncogene. 2014 May 1; 33(18):2385-94. PMID: 23708659; PMCID: PMC4026278.
    26. McCoy F, Darbandi R, Chen SI, Eckard L, Dodd K, Jones K, Baucum AJ, Gibbons JA, Lin SH, Colbran RJ, Nutt LK. Metabolic regulation of CaMKII protein and caspases in Xenopus laevis egg extracts. J Biol Chem. 2013 Mar 29; 288(13):8838-48. PMID: 23400775; PMCID: PMC3610959.
    27. Lee YC, Jin JK, Cheng CJ, Huang CF, Song JH, Huang M, Brown WS, Zhang S, Yu-Lee LY, Yeh ET, McIntyre BW, Logothetis CJ, Gallick GE, Lin SH. Targeting constitutively activated ?1 integrins inhibits prostate cancer metastasis. Mol Cancer Res. 2013 Apr; 11(4):405-17. PMID: 23339185; PMCID: PMC3631285.
    28. Deeraksa A, Pan J, Sha Y, Liu XD, Eissa NT, Lin SH, Yu-Lee LY. Plk1 is upregulated in androgen-insensitive prostate cancer cells and its inhibition leads to necroptosis. Oncogene. 2013 Jun 13; 32(24):2973-83. PMID: 22890325; PMCID: PMC3499666.
    29. Fadri-Moskwik M, Weiderhold KN, Deeraksa A, Chuang C, Pan J, Lin SH, Yu-Lee LY. Aurora B is regulated by acetylation/deacetylation during mitosis in prostate cancer cells. FASEB J. 2012 Oct; 26(10):4057-67. PMID: 22751009; PMCID: PMC3448774.
    30. Tu SM, Lin SH. Prostate cancer stem cells. Clin Genitourin Cancer. 2012 Jun; 10(2):69-76. PMID: 22421313.
      View in: PubMed
    31. Gallick GE, Corn PG, Zurita AJ, Lin SH. Small-molecule protein tyrosine kinase inhibitors for the treatment of metastatic prostate cancer. Future Med Chem. 2012 Jan; 4(1):107-19. PMID: 22168167.
      View in: PubMed
    32. Ortiz A, Lin SH. Osteolytic and osteoblastic bone metastases: two extremes of the same spectrum? Recent Results Cancer Res. 2012; 192:225-33. PMID: 22307378.
      View in: PubMed
    33. Lee YC, Srajer Gajdosik M, Josic D, Lin SH. Plasma membrane isolation using immobilized concanavalin A magnetic beads. Methods Mol Biol. 2012; 909:29-41. PMID: 22903707.
      View in: PubMed
    34. Xie X, Qin J, Lin SH, Tsai SY, Tsai MJ. Nuclear receptor chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII) modulates mesenchymal cell commitment and differentiation. Proc Natl Acad Sci U S A. 2011 Sep 6; 108(36):14843-8. PMID: 21873211; PMCID: PMC3169151.
    35. Ye X, Lee YC, Choueiri M, Chu K, Huang CF, Tsai WW, Kobayashi R, Logothetis CJ, Yu-Lee LY, Lin SH. Aberrant expression of katanin p60 in prostate cancer bone metastasis. Prostate. 2012 Feb; 72(3):291-300. PMID: 21681775; PMCID: PMC3179562.
    36. Lee YC, Cheng CJ, Bilen MA, Lu JF, Satcher RL, Yu-Lee LY, Gallick GE, Maity SN, Lin SH. BMP4 promotes prostate tumor growth in bone through osteogenesis. Cancer Res. 2011 Aug 1; 71(15):5194-203. PMID: 21670081; PMCID: PMC3148283.
    37. Li J, Khavandgar Z, Lin SH, Murshed M. Lithium chloride attenuates BMP-2 signaling and inhibits osteogenic differentiation through a novel WNT/GSK3- independent mechanism. Bone. 2011 Feb; 48(2):321-31. PMID: 20932949.
      View in: PubMed
    38. Chuang C, Lin SH, Huang F, Pan J, Josic D, Yu-Lee LY. Acetylation of RNA processing proteins and cell cycle proteins in mitosis. J Proteome Res. 2010 Sep 3; 9(9):4554-64. PMID: 20812760; PMCID: PMC2935306.
    39. Tsai WB, Chung YM, Zou Y, Park SH, Xu Z, Nakayama K, Lin SH, Hu MC. Inhibition of FOXO3 tumor suppressor function by betaTrCP1 through ubiquitin-mediated degradation in a tumor mouse model. PLoS One. 2010; 5(7):e11171. PMID: 20625400; PMCID: PMC2896402.
    40. Bawa-Khalfe T, Cheng J, Lin SH, Ittmann MM, Yeh ET. SENP1 induces prostatic intraepithelial neoplasia through multiple mechanisms. J Biol Chem. 2010 Aug 13; 285(33):25859-66. PMID: 20551310; PMCID: PMC2919148.
    41. Yang G, Rosen DG, Liu G, Yang F, Guo X, Xiao X, Xue F, Mercado-Uribe I, Huang J, Lin SH, Mills GB, Liu J. CXCR2 promotes ovarian cancer growth through dysregulated cell cycle, diminished apoptosis, and enhanced angiogenesis. Clin Cancer Res. 2010 Aug 1; 16(15):3875-86. PMID: 20505188; PMCID: PMC2930833.
    42. Huang CF, Lira C, Chu K, Bilen MA, Lee YC, Ye X, Kim SM, Ortiz A, Wu FL, Logothetis CJ, Yu-Lee LY, Lin SH. Cadherin-11 increases migration and invasion of prostate cancer cells and enhances their interaction with osteoblasts. Cancer Res. 2010 Jun 1; 70(11):4580-9. PMID: 20484040; PMCID: PMC2923552.
    43. Liu G, Yang G, Chang B, Mercado-Uribe I, Huang M, Zheng J, Bast RC, Lin SH, Liu J. Stanniocalcin 1 and ovarian tumorigenesis. J Natl Cancer Inst. 2010 Jun 2; 102(11):812-27. PMID: 20484106.
      View in: PubMed
    44. Tu SM, Lin SH, Podoloff DA, Logothetis CJ. Multimodality therapy: bone-targeted radioisotope therapy of prostate cancer. Clin Adv Hematol Oncol. 2010 May; 8(5):341-51. PMID: 20551894.
      View in: PubMed
    45. Lee YC, Cheng CJ, Huang M, Bilen MA, Ye X, Navone NM, Chu K, Kao HH, Yu-Lee LY, Wang Z, Lin SH. Androgen depletion up-regulates cadherin-11 expression in prostate cancer. J Pathol. 2010 May; 221(1):68-76. PMID: 20191612; PMCID: PMC2936767.
    46. Lee YC, Huang CF, Murshed M, Chu K, Araujo JC, Ye X, deCrombrugghe B, Yu-Lee LY, Gallick GE, Lin SH. Src family kinase/abl inhibitor dasatinib suppresses proliferation and enhances differentiation of osteoblasts. Oncogene. 2010 Jun 3; 29(22):3196-207. PMID: 20228840; PMCID: PMC2921959.
    47. Wu CF, Wang R, Liang Q, Liang J, Li W, Jung SY, Qin J, Lin SH, Kuang J. Dissecting the M phase-specific phosphorylation of serine-proline or threonine-proline motifs. Mol Biol Cell. 2010 May 1; 21(9):1470-81. PMID: 20219976; PMCID: PMC2861607.
    48. Zhang S, Wang J, Bilen MA, Lin SH, Stupp SI, Satcher RL. Modulation of prostate cancer cell gene expression by cell-to-cell contact with bone marrow stromal cells or osteoblasts. Clin Exp Metastasis. 2009; 26(8):993-1004. PMID: 19787436.
      View in: PubMed
    49. Zhou X, Pan S, Sun L, Corvera J, Lee YC, Lin SH, Kuang J. The CHMP4b- and Src-docking sites in the Bro1 domain are autoinhibited in the native state of Alix. Biochem J. 2009 Mar 1; 418(2):277-84. PMID: 19016654.
      View in: PubMed
    50. Lin SH, Guidotti G. Purification of membrane proteins. Methods Enzymol. 2009; 463:619-29. PMID: 19892195.
      View in: PubMed
    51. Mathew P, Thall PF, Wen S, Bucana C, Jones D, Horne E, Oh WK, Morris MJ, Lee YC, Logothetis CJ, Lin SH, Fidler IJ. Dynamic change in phosphorylated platelet-derived growth factor receptor in peripheral blood leukocytes following docetaxel therapy predicts progression-free and overall survival in prostate cancer. Br J Cancer. 2008 Nov 4; 99(9):1426-32. PMID: 18841158; PMCID: PMC2579696.
    52. Zhou X, Pan S, Sun L, Corvera J, Lin SH, Kuang J. The HIV-1 p6/EIAV p9 docking site in Alix is autoinhibited as revealed by a conformation-sensitive anti-Alix monoclonal antibody. Biochem J. 2008 Sep 1; 414(2):215-20. PMID: 18476810.
      View in: PubMed
    53. Lee YC, Block G, Chen H, Folch-Puy E, Foronjy R, Jalili R, Jendresen CB, Kimura M, Kraft E, Lindemose S, Lu J, McLain T, Nutt L, Ramon-Garcia S, Smith J, Spivak A, Wang ML, Zanic M, Lin SH. One-step isolation of plasma membrane proteins using magnetic beads with immobilized concanavalin A. Protein Expr Purif. 2008 Dec; 62(2):223-9. PMID: 18765283; PMCID: PMC2600885.
    54. Li ZG, Mathew P, Yang J, Starbuck MW, Zurita AJ, Liu J, Sikes C, Multani AS, Efstathiou E, Lopez A, Wang J, Fanning TV, Prieto VG, Kundra V, Vazquez ES, Troncoso P, Raymond AK, Logothetis CJ, Lin SH, Maity S, Navone NM. Androgen receptor-negative human prostate cancer cells induce osteogenesis in mice through FGF9-mediated mechanisms. J Clin Invest. 2008 Aug; 118(8):2697-710. PMID: 18618013; PMCID: PMC2447924.
    55. Chu K, Cheng CJ, Ye X, Lee YC, Zurita AJ, Chen DT, Yu-Lee LY, Zhang S, Yeh ET, Hu MC, Logothetis CJ, Lin SH. Cadherin-11 promotes the metastasis of prostate cancer cells to bone. Mol Cancer Res. 2008 Aug; 6(8):1259-67. PMID: 18708358; PMCID: PMC2643879.
    56. Pan S, Wang R, Zhou X, Corvera J, Kloc M, Sifers R, Gallick GE, Lin SH, Kuang J. Extracellular Alix regulates integrin-mediated cell adhesions and extracellular matrix assembly. EMBO J. 2008 Aug 6; 27(15):2077-90. PMID: 18636094; PMCID: PMC2516883.
    57. Lira CB, Chu K, Lee YC, Hu MC, Lin SH. Expression of the extracellular domain of OB-cadherin as an Fc fusion protein using bicistronic retroviral expression vector. Protein Expr Purif. 2008 Oct; 61(2):220-6. PMID: 18620062; PMCID: PMC2597006.
    58. Lin SH, Lee YC, Choueiri MB, Wen S, Mathew P, Ye X, Do KA, Navone NM, Kim J, Tu SM, Yu-Lee LY, Logothetis CJ. Soluble ErbB3 levels in bone marrow and plasma of men with prostate cancer. Clin Cancer Res. 2008 Jun 15; 14(12):3729-36. PMID: 18559590; PMCID: PMC2562877.
    59. García C, Aranda J, Arnold E, Thébault S, Macotela Y, López-Casillas F, Mendoza V, Quiroz-Mercado H, Hernández-Montiel HL, Lin SH, de la Escalera GM, Clapp C. Vasoinhibins prevent retinal vasopermeability associated with diabetic retinopathy in rats via protein phosphatase 2A-dependent eNOS inactivation. J Clin Invest. 2008 Jun; 118(6):2291-300. PMID: 18497878; PMCID: PMC2391065.
    60. Lin SH, Cheng CJ, Lee YC, Ye X, Tsai WW, Kim J, Pasqualini R, Arap W, Navone NM, Tu SM, Hu M, Yu-Lee LY, Logothetis CJ. A 45-kDa ErbB3 secreted by prostate cancer cells promotes bone formation. Oncogene. 2008 Sep 4; 27(39):5195-203. PMID: 18490922; PMCID: PMC2562662.
    61. Logothetis CJ, Navone NM, Lin SH. Understanding the biology of bone metastases: key to the effective treatment of prostate cancer. Clin Cancer Res. 2008 Mar 15; 14(6):1599-602. PMID: 18347159.
      View in: PubMed
    62. Zou Y, Tsai WB, Cheng CJ, Hsu C, Chung YM, Li PC, Lin SH, Hu MC. Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis. Breast Cancer Res. 2008; 10(1):R21. PMID: 18312651; PMCID: PMC2374977.
    63. Tu SM, Lin SH. Current trials using bone-targeting agents in prostate cancer. Cancer J. 2008 Jan-Feb; 14(1):35-9. PMID: 18303481.
      View in: PubMed
    64. Lee SH, Kunz J, Lin SH, Yu-Lee LY. 16-kDa prolactin inhibits endothelial cell migration by down-regulating the Ras-Tiam1-Rac1-Pak1 signaling pathway. Cancer Res. 2007 Nov 15; 67(22):11045-53. PMID: 18006851.
      View in: PubMed
    65. Li ZG, Yang J, Vazquez ES, Rose D, Vakar-Lopez F, Mathew P, Lopez A, Logothetis CJ, Lin SH, Navone NM. Low-density lipoprotein receptor-related protein 5 (LRP5) mediates the prostate cancer-induced formation of new bone. Oncogene. 2008 Jan 24; 27(5):596-603. PMID: 17700537.
      View in: PubMed
    66. Chen N, Ye XC, Chu K, Navone NM, Sage EH, Yu-Lee LY, Logothetis CJ, Lin SH. A secreted isoform of ErbB3 promotes osteonectin expression in bone and enhances the invasiveness of prostate cancer cells. Cancer Res. 2007 Jul 15; 67(14):6544-8. PMID: 17638862; PMCID: PMC2000837.
    67. Cheng CJ, Ye XC, Vakar-Lopez F, Kim J, Tu SM, Chen DT, Navone NM, Yu-Lee LY, Lin SH, Hu MC. Bone microenvironment and androgen status modulate subcellular localization of ErbB3 in prostate cancer cells. Mol Cancer Res. 2007 Jul; 5(7):675-84. PMID: 17634423; PMCID: PMC2000833.
    68. Ye XC, Choueiri M, Tu SM, Lin SH. Biology and clinical management of prostate cancer bone metastasis. Front Biosci. 2007; 12:3273-86. PMID: 17485298.
      View in: PubMed
    69. Chen DT, Chen JJ, Cheng G, Lin SH, Soong SJ. A two-stage binomial test approach of gene identification in oligonucleotide arrays. J Biopharm Stat. 2007; 17(5):903-18. PMID: 17885873.
      View in: PubMed
    70. Choueiri MB, Tu SM, Yu-Lee LY, Lin SH. The central role of osteoblasts in the metastasis of prostate cancer. Cancer Metastasis Rev. 2006 Dec; 25(4):601-9. PMID: 17160554.
      View in: PubMed
    71. Nagaishi T, Pao L, Lin SH, Iijima H, Kaser A, Qiao SW, Chen Z, Glickman J, Najjar SM, Nakajima A, Neel BG, Blumberg RS. SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms. Immunity. 2006 Nov; 25(5):769-81. PMID: 17081782.
      View in: PubMed
    72. Tannir N, Jonasch E, Pagliaro LC, Mathew P, Siefker-Radtke A, Rhines L, Lin P, Tibbs R, Do KA, Lin SH, Tu SM. Pilot trial of bone-targeted therapy with zoledronate, thalidomide, and interferon-gamma for metastatic renal cell carcinoma. Cancer. 2006 Aug 1; 107(3):497-505. PMID: 16795067.
      View in: PubMed
    73. Nishino M, Kurasawa Y, Evans R, Lin SH, Brinkley BR, Yu-Lee LY. NudC is required for Plk1 targeting to the kinetochore and chromosome congression. Curr Biol. 2006 Jul 25; 16(14):1414-21. PMID: 16860740.
      View in: PubMed
    74. Liang AK, Liu J, Mao SA, Siu VS, Lee YC, Lin SH. Expression of recombinant MDA-BF-1 with a kinase recognition site and a 7-histidine tag for receptor binding and purification. Protein Expr Purif. 2005 Nov; 44(1):58-64. PMID: 15914029.
      View in: PubMed
    75. Tu SM, Kim J, Pagliaro LC, Vakar-Lopez F, Wong FC, Wen S, General R, Podoloff DA, Lin SH, Logothetis CJ. Therapy tolerance in selected patients with androgen-independent prostate cancer following strontium-89 combined with chemotherapy. J Clin Oncol. 2005 Nov 1; 23(31):7904-10. PMID: 16258090.
      View in: PubMed
    76. Zhou HJ, Yan J, Luo W, Ayala G, Lin SH, Erdem H, Ittmann M, Tsai SY, Tsai MJ. SRC-3 is required for prostate cancer cell proliferation and survival. Cancer Res. 2005 Sep 1; 65(17):7976-83. PMID: 16140970.
      View in: PubMed
    77. Lee SH, Nishino M, Mazumdar T, Garcia GE, Galfione M, Lee FL, Lee CL, Liang A, Kim J, Feng L, Eissa NT, Lin SH, Yu-Lee LY. 16-kDa prolactin down-regulates inducible nitric oxide synthase expression through inhibition of the signal transducer and activator of transcription 1/IFN regulatory factor-1 pathway. Cancer Res. 2005 Sep 1; 65(17):7984-92. PMID: 16140971.
      View in: PubMed
    78. Najjar SM, Yang Y, Fernström MA, Lee SJ, Deangelis AM, Rjaily GA, Al-Share QY, Dai T, Miller TA, Ratnam S, Ruch RJ, Smith S, Lin SH, Beauchemin N, Oyarce AM. Insulin acutely decreases hepatic fatty acid synthase activity. Cell Metab. 2005 Jul; 2(1):43-53. PMID: 16054098.
      View in: PubMed
    79. Logothetis CJ, Lin SH. Osteoblasts in prostate cancer metastasis to bone. Nat Rev Cancer. 2005 Jan; 5(1):21-8. PMID: 15630412.
      View in: PubMed
    80. Britt DE, Yang DF, Yang DQ, Flanagan D, Callanan H, Lim YP, Lin SH, Hixson DC. Identification of a novel protein, LYRIC, localized to tight junctions of polarized epithelial cells. Exp Cell Res. 2004 Oct 15; 300(1):134-48. PMID: 15383321.
      View in: PubMed
    81. Abou-Rjaily GA, Lee SJ, May D, Al-Share QY, Deangelis AM, Ruch RJ, Neumaier M, Kalthoff H, Lin SH, Najjar SM. CEACAM1 modulates epidermal growth factor receptor--mediated cell proliferation. J Clin Invest. 2004 Oct; 114(7):944-52. PMID: 15467833.
      View in: PubMed
    82. Gonzalez C, Corbacho AM, Eiserich JP, Garcia C, Lopez-Barrera F, Morales-Tlalpan V, Barajas-Espinosa A, Diaz-Muñoz M, Rubio R, Lin SH, Martinez de la Escalera G, Clapp C. 16K-prolactin inhibits activation of endothelial nitric oxide synthase, intracellular calcium mobilization, and endothelium-dependent vasorelaxation. Endocrinology. 2004 Dec; 145(12):5714-22. PMID: 15358675.
      View in: PubMed
    83. Comegys MM, Lin SH, Rand D, Britt D, Flanagan D, Callanan H, Brilliant K, Hixson DC. Two variable regions in carcinoembryonic antigen-related cell adhesion molecule1 N-terminal domains located in or next to monoclonal antibody and adhesion epitopes show evidence of recombination in rat but not in human. J Biol Chem. 2004 Aug 13; 279(33):35063-78. PMID: 15184366.
      View in: PubMed
    84. Vakar-Lopez F, Cheng CJ, Kim J, Shi GG, Troncoso P, Tu SM, Yu-Lee LY, Lin SH. Up-regulation of MDA-BF-1, a secreted isoform of ErbB3, in metastatic prostate cancer cells and activated osteoblasts in bone marrow. J Pathol. 2004 Jun; 203(2):688-95. PMID: 15141384.
      View in: PubMed
    85. Phan D, Cheng CJ, Galfione M, Vakar-Lopez F, Tunstead J, Thompson NE, Burgess RR, Najjar SM, Yu-Lee LY, Lin SH. Identification of Sp2 as a transcriptional repressor of carcinoembryonic antigen-related cell adhesion molecule 1 in tumorigenesis. Cancer Res. 2004 May 1; 64(9):3072-8. PMID: 15126343.
      View in: PubMed
    86. Lin SH, Nishino M, Luo W, Aumais JP, Galfione M, Kuang J, Yu-Lee LY. Inhibition of prostate tumor growth by overexpression of NudC, a microtubule motor-associated protein. Oncogene. 2004 Apr 1; 23(14):2499-506. PMID: 14676831.
      View in: PubMed
    87. Chen DT, Lin SH, Soong SJ. Gene selection for oligonucleotide array: an approach using PM probe level data. Bioinformatics. 2004 Apr 12; 20(6):854-62. PMID: 14752002.
      View in: PubMed
    88. Tu SM, Lin SH, Logothetis C. Re: A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma. J Natl Cancer Inst. 2003 Aug 6; 95(15):1174-5; author reply 1175. PMID: 12902452.
      View in: PubMed
    89. Aumais JP, Williams SN, Luo W, Nishino M, Caldwell KA, Caldwell GA, Lin SH, Yu-Lee LY. Role for NudC, a dynein-associated nuclear movement protein, in mitosis and cytokinesis. J Cell Sci. 2003 May 15; 116(Pt 10):1991-2003. PMID: 12679384.
      View in: PubMed
    90. Galfione M, Luo W, Kim J, Hawke D, Kobayashi R, Clapp C, Yu-Lee LY, Lin SH. Expression and purification of the angiogenesis inhibitor 16-kDa prolactin fragment from insect cells. Protein Expr Purif. 2003 Apr; 28(2):252-8. PMID: 12699689.
      View in: PubMed
    91. Kim J, Luo W, Chen DT, Earley K, Tunstead J, Yu-Lee LY, Lin SH. Antitumor activity of the 16-kDa prolactin fragment in prostate cancer. Cancer Res. 2003 Jan 15; 63(2):386-93. PMID: 12543792.
      View in: PubMed
    92. Wu Y, Pan S, Luo W, Lin SH, Kuang J. Hp95 promotes anoikis and inhibits tumorigenicity of HeLa cells. Oncogene. 2002 Oct 3; 21(44):6801-8. PMID: 12360406.
      View in: PubMed
    93. Pu YS, Do KA, Luo W, Logothetis CJ, Lin SH. Enhanced suppression of prostate tumor growth by combining C-CAM1 gene therapy and angiogenesis inhibitor TNP-470. Anticancer Drugs. 2002 Aug; 13(7):743-9. PMID: 12187331.
      View in: PubMed
    94. Tu SM, Lin SH, Logothetis CJ. Stem-cell origin of metastasis and heterogeneity in solid tumours. Lancet Oncol. 2002 Aug; 3(8):508-13. PMID: 12147437.
      View in: PubMed
    95. Volpert O, Luo W, Liu TJ, Estrera VT, Logothetis C, Lin SH. Inhibition of prostate tumor angiogenesis by the tumor suppressor CEACAM1. J Biol Chem. 2002 Sep 20; 277(38):35696-702. PMID: 12122002.
      View in: PubMed
    96. Sweeney P, El-Naggar AK, Lin SH, Pisters LL. Biological significance of c-met over expression in papillary renal cell carcinoma. J Urol. 2002 Jul; 168(1):51-5. PMID: 12050491.
      View in: PubMed
    97. Tu SM, Reyes A, Maa A, Bhowmick D, Pisters LL, Pettaway CA, Lin SH, Troncoso P, Logothetis CJ. Prostate carcinoma with testicular or penile metastases. Clinical, pathologic, and immunohistochemical features. Cancer. 2002 May 15; 94(10):2610-7. PMID: 12173328.
      View in: PubMed
    98. Chua SS, Ma ZQ, Gong L, Lin SH, DeMayo FJ, Tsai SY. Ectopic expression of FGF-3 results in abnormal prostate and Wolffian duct development. Oncogene. 2002 Mar 14; 21(12):1899-908. PMID: 11896623.
      View in: PubMed
    99. Aumais JP, Tunstead JR, McNeil RS, Schaar BT, McConnell SK, Lin SH, Clark GD, Yu-Lee LY. NudC associates with Lis1 and the dynein motor at the leading pole of neurons. J Neurosci. 2001 Dec 15; 21(24):RC187. PMID: 11734602.
      View in: PubMed
    100. Phan D, Sui X, Chen DT, Najjar SM, Jenster G, Lin SH. Androgen regulation of the cell-cell adhesion molecule-1 (Ceacam1) gene. Mol Cell Endocrinol. 2001 Nov 26; 184(1-2):115-23. PMID: 11694347.
      View in: PubMed
    101. Han E, Phan D, Lo P, Poy MN, Behringer R, Najjar SM, Lin SH. Differences in tissue-specific and embryonic expression of mouse Ceacam1 and Ceacam2 genes. Biochem J. 2001 Apr 15; 355(Pt 2):417-23. PMID: 11284729; PMCID: PMC1221753.
    102. Phan D, Han E, Birrell G, Bonnal S, Duggan L, Esumi N, Gutstein H, Li R, Lopato S, Manogaran A, Pollak ES, Ray A, Reddi PP, Reichert AS, Struffi P, Tiscornia G, Ximenez-Fyvie LA, Zhang H, Lin SH. Purification and characterization of human cell--cell adhesion molecule 1 (C-CAM1) expressed in insect cells. Protein Expr Purif. 2001 Mar; 21(2):343-51. PMID: 11237697.
      View in: PubMed
    103. Estrera VT, Chen DT, Luo W, Hixson DC, Lin SH. Signal transduction by the CEACAM1 tumor suppressor. Phosphorylation of serine 503 is required for growth-inhibitory activity. J Biol Chem. 2001 May 4; 276(18):15547-53. PMID: 11278391.
      View in: PubMed
    104. Wang Y, Liu J, Wu Y, Luo W, Lin SH, Lin H, Hawk N, Sun T, Guo JQ, Estrov Z, Talpaz M, Champlin R, Arlinghaus RB. Expression of a truncated first exon BCR sequence in chronic myelogenous leukemia cells blocks cell growth and induces cell death. Cancer Res. 2001 Jan 1; 61(1):138-44. PMID: 11196151.
      View in: PubMed
    105. Wang L, Lin SH, Wu WG, Kemp BL, Walsh GL, Hong WK, Mao L. C-CAM1, a candidate tumor suppressor gene, is abnormally expressed in primary lung cancers. Clin Cancer Res. 2000 Aug; 6(8):2988-93. PMID: 10955775.
      View in: PubMed
    106. Beauchemin N, Draber P, Dveksler G, Gold P, Gray-Owen S, Grunert F, Hammarström S, Holmes KV, Karlsson A, Kuroki M, Lin SH, Lucka L, Najjar SM, Neumaier M, Obrink B, Shively JE, Skubitz KM, Stanners CP, Thomas P, Thompson JA, Virji M, von Kleist S, Wagener C, Watt S, Zimmermann W. Redefined nomenclature for members of the carcinoembryonic antigen family. Exp Cell Res. 1999 Nov 1; 252(2):243-9. PMID: 11501563.
      View in: PubMed
    107. Estrera VT, Luo W, Phan D, Earley K, Hixson DC, Lin SH. The cytoplasmic domain of C-CAM1 tumor suppressor is necessary and sufficient for suppressing the tumorigenicity of prostate cancer cells. Biochem Biophys Res Commun. 1999 Oct 5; 263(3):797-803. PMID: 10512760.
      View in: PubMed
    108. Hsieh JT, Earley K, Pong RC, Wang Y, Van NT, Lin SH. Structural analysis of the C-CAM1 molecule for its tumor suppression function in human prostate cancer. Prostate. 1999 Sep 15; 41(1):31-8. PMID: 10440873.
      View in: PubMed
    109. Pu YS, Luo W, Lu HH, Greenberg NM, Lin SH, Gingrich JR. Differential expression of C-CAM cell adhesion molecule in prostate carcinogenesis in a transgenic mouse model. J Urol. 1999 Sep; 162(3 Pt 1):892-6. PMID: 10458403.
      View in: PubMed
    110. Luo W, Tapolsky M, Earley K, Wood CG, Wilson DR, Logothetis CJ, Lin SH. Tumor-suppressive activity of CD66a in prostate cancer. Cancer Gene Ther. 1999 Jul-Aug; 6(4):313-21. PMID: 10419049.
      View in: PubMed
    111. Makarovskiy AN, Pu YS, Lo P, Earley K, Paglia M, Hixson DC, Lin SH. Expression and androgen regulation of C-CAM cell adhesion molecule isoforms in rat dorsal and ventral prostate. Oncogene. 1999 May 27; 18(21):3252-60. PMID: 10359531.
      View in: PubMed
    112. Comegys MM, Carreiro MP, Brown JF, Mazzacua A, Flanagan DL, Makarovskiy A, Lin SH, Hixson DC. C-CAM1 expression: differential effects on morphology, differentiation state and suppression of human PC-3 prostate carcinoma cells. Oncogene. 1999 May 27; 18(21):3261-76. PMID: 10359532.
      View in: PubMed
    113. Lin SH, Pu YS. Function and therapeutic implication of C-CAM cell-adhesion molecule in prostate cancer. Semin Oncol. 1999 Apr; 26(2):227-33. PMID: 10597733.
      View in: PubMed
    114. Lin SH, Pu YS, Luo W, Wang Y, Logothetis CJ. Schedule-dependence of C-CAM1 adenovirus gene therapy in a prostate cancer model. Anticancer Res. 1999 Jan-Feb; 19(1A):337-40. PMID: 10226564.
      View in: PubMed
    115. Mannion BA, Kolesnikova TV, Lin SH, Wang S, Thompson NL, Hemler ME. The light chain of CD98 is identified as E16/TA1 protein. J Biol Chem. 1998 Dec 11; 273(50):33127-9. PMID: 9837878.
      View in: PubMed
    116. Su LK, Wang SC, Qi Y, Luo W, Hung MC, Lin SH. Characterization of BRCA2: temperature sensitivity of detection and cell-cycle regulated expression. Oncogene. 1998 Nov 5; 17(18):2377-81. PMID: 9811469.
      View in: PubMed
    117. Chen ME, Lin SH, Chung LW, Sikes RA. Isolation and characterization of PAGE-1 and GAGE-7. New genes expressed in the LNCaP prostate cancer progression model that share homology with melanoma-associated antigens. J Biol Chem. 1998 Jul 10; 273(28):17618-25. PMID: 9651357.
      View in: PubMed
    118. Lin SH, Cheng H, Earley K, Luo W, Chou J. Demonstration of adhesion activity of the soluble Ig-domain protein C-CAM4 by attachment to the plasma membrane. Biochem Biophys Res Commun. 1998 Apr 17; 245(2):472-7. PMID: 9571177.
      View in: PubMed
    119. Luo W, Earley K, Tantingco V, Hixson DC, Liang TC, Lin SH. Association of an 80 kDa protein with C-CAM1 cytoplasmic domain correlates with C-CAM1-mediated growth inhibition. Oncogene. 1998 Mar 5; 16(9):1141-7. PMID: 9528856.
      View in: PubMed
    120. Luo W, Lin SH. Generation of moderate amounts of polyclonal antibodies in mice. Biotechniques. 1997 Oct; 23(4):630-2. PMID: 9343678.
      View in: PubMed
    121. Pisters LL, el-Naggar AK, Luo W, Malpica A, Lin SH. C-met proto-oncogene expression in benign and malignant human renal tissues. J Urol. 1997 Sep; 158(3 Pt 1):724-8. PMID: 9258068.
      View in: PubMed
    122. Wang SC, Lin SH, Su LK, Hung MC. Changes in BRCA2 expression during progression of the cell cycle. Biochem Biophys Res Commun. 1997 May 8; 234(1):247-51. PMID: 9168997.
      View in: PubMed
    123. Luo W, Wood CG, Earley K, Hung MC, Lin SH. Suppression of tumorigenicity of breast cancer cells by an epithelial cell adhesion molecule (C-CAM1): the adhesion and growth suppression are mediated by different domains. Oncogene. 1997 Apr 10; 14(14):1697-704. PMID: 9135071.
      View in: PubMed
    124. Kleinerman DI, Dinney CP, Zhang WW, Lin SH, Van NT, Hsieh JT. Suppression of human bladder cancer growth by increased expression of C-CAM1 gene in an orthotopic model. Cancer Res. 1996 Aug 1; 56(15):3431-5. PMID: 8758907.
      View in: PubMed
    125. Liang TC, Luo W, Hsieh JT, Lin SH. Antibody binding to a peptide but not the whole protein by recognition of the C-terminal carboxy group. Arch Biochem Biophys. 1996 May 15; 329(2):208-14. PMID: 8638953.
      View in: PubMed
    126. Luo W, Liang TC, Li JM, Hsieh JT, Lin SH. A universal tag for recombinant proteins. Arch Biochem Biophys. 1996 May 15; 329(2):215-20. PMID: 8638954.
      View in: PubMed
    127. Earley K, Luo W, Qiu Y, Thompson NL, Chou J, Hixson DC, Lin SH. Identification of a new isoform of cell-cell adhesion molecule 105 (C-CAM), C-CAM4: a secretory protein with only one Ig domain. Biochem J. 1996 May 1; 315 ( Pt 3):799-806. PMID: 8645160; PMCID: PMC1217277.
    128. Chapman L, Sang J, Lin SH, Hixson DC, Thompson NL. Cloning of cDNAs from a mammalian expression library by a direct selection-amplification method. Mol Biotechnol. 1996 Apr; 5(2):77-83. PMID: 8734421.
      View in: PubMed
    129. Chen X, Earley K, Luo W, Lin SH, Schilling WP. Functional expression of a human thrombin receptor in Sf9 insect cells: evidence for an active tethered ligand. Biochem J. 1996 Mar 1; 314 ( Pt 2):603-11. PMID: 8670076; PMCID: PMC1217091.
    130. Lin SH, Luo W, Earley K, Cheung P, Hixson DC. Structure and function of C-CAM1: effects of the cytoplasmic domain on cell aggregation. Biochem J. 1995 Oct 1; 311 ( Pt 1):239-45. PMID: 7575460; PMCID: PMC1136144.
    131. Kleinerman DI, Zhang WW, Lin SH, Nguyen TV, von Eschenbach AC, Hsieh JT. Application of a tumor suppressor (C-CAM1)-expressing recombinant adenovirus in androgen-independent human prostate cancer therapy: a preclinical study. Cancer Res. 1995 Jul 1; 55(13):2831-6. PMID: 7796410.
      View in: PubMed
    132. Kleinerman DI, Troncoso P, Lin SH, Pisters LL, Sherwood ER, Brooks T, von Eschenbach AC, Hsieh JT. Consistent expression of an epithelial cell adhesion molecule (C-CAM) during human prostate development and loss of expression in prostate cancer: implication as a tumor suppressor. Cancer Res. 1995 Mar 15; 55(6):1215-20. PMID: 7533659.
      View in: PubMed
    133. Baum O, Reutter W, Flanagan D, Callanan H, Lim YP, Lin SH, Hixson DC. Anti-peptide sera against cell-CAM 105 determine high molecular-mass variants of the long isoform in rat hepatocytes. Eur J Biochem. 1995 Mar 1; 228(2):316-22. PMID: 7705345.
      View in: PubMed
    134. Hsieh JT, Luo W, Song W, Wang Y, Kleinerman DI, Van NT, Lin SH. Tumor suppressive role of an androgen-regulated epithelial cell adhesion molecule (C-CAM) in prostate carcinoma cell revealed by sense and antisense approaches. Cancer Res. 1995 Jan 1; 55(1):190-7. PMID: 7805032.
      View in: PubMed
    135. Hsieh JT, Lin SH. Androgen regulation of cell adhesion molecule gene expression in rat prostate during organ degeneration. C-CAM belongs to a class of androgen-repressed genes associated with enriched stem/amplifying cell population after prolonged castration. J Biol Chem. 1994 Feb 4; 269(5):3711-6. PMID: 8106416.
      View in: PubMed
    136. Thompson NL, Lin SH, Panzica MA, Hixson DC. Cell CAM 105 isoform RNA expression is differentially regulated during rat liver regeneration and carcinogenesis. Pathobiology. 1994; 62(4):209-20. PMID: 7734064.
      View in: PubMed
    137. Cheung PH, Luo W, Qiu Y, Zhang X, Earley K, Millirons P, Lin SH. Structure and function of C-CAM1. The first immunoglobulin domain is required for intercellular adhesion. J Biol Chem. 1993 Nov 15; 268(32):24303-10. PMID: 8226979.
      View in: PubMed
    138. Cheung PH, Culic O, Qiu Y, Earley K, Thompson N, Hixson DC, Lin SH. The cytoplasmic domain of C-CAM is required for C-CAM-mediated adhesion function: studies of a C-CAM transcript containing an unspliced intron. Biochem J. 1993 Oct 15; 295 ( Pt 2):427-35. PMID: 8240240; PMCID: PMC1134899.
    139. Lim YP, Callanan H, Lin SH, Thompson NL, Hixson DC. Preparative mini-slab gel continuous elution electrophoresis: application for the separation of two isoforms of rat hepatocyte cell adhesion molecule, cell-CAM 105, and its associated proteins. Anal Biochem. 1993 Oct; 214(1):156-64. PMID: 8250219.
      View in: PubMed
    140. Cheung PH, Earley K, Liang TC, Lin SH. Conformation dependence of antipeptide antibodies: characterization of cell-CAM105 isoform-specific antipeptide antibodies using proteins expressed in insect cells with baculoviral vectors. Arch Biochem Biophys. 1993 Sep; 305(2):563-9. PMID: 8373195.
      View in: PubMed
    141. Thompson NL, Panzica MA, Hull G, Lin SH, Curran TR, Gruppuso PA, Baum O, Reutter W, Hixson DC. Spatiotemporal expression of two cell-cell adhesion molecule 105 isoforms during liver development. Cell Growth Differ. 1993 Apr; 4(4):257-68. PMID: 8494790.
      View in: PubMed
    142. Cheung PH, Thompson NL, Earley K, Culic O, Hixson D, Lin SH. Cell-CAM105 isoforms with different adhesion functions are coexpressed in adult rat tissues and during liver development. J Biol Chem. 1993 Mar 25; 268(9):6139-46. PMID: 8454589.
      View in: PubMed
    143. Holmes KV, Dveksler G, Gagneten S, Yeager C, Lin SH, Beauchemin N, Look AT, Ashmun R, Dieffenbach C. Coronavirus receptor specificity. Adv Exp Med Biol. 1993; 342:261-6. PMID: 8209740.
      View in: PubMed
    144. Culic O, Huang QH, Flanagan D, Hixson D, Lin SH. Molecular cloning and expression of a new rat liver cell-CAM105 isoform. Differential phosphorylation of isoforms. Biochem J. 1992 Jul 1; 285 ( Pt 1):47-53. PMID: 1637321; PMCID: PMC1132742.
    145. Lin SH, Culic O, Flanagan D, Hixson DC. Immunochemical characterization of two isoforms of rat liver ecto-ATPase that show an immunological and structural identity with a glycoprotein cell-adhesion molecule with Mr 105,000. Biochem J. 1991 Aug 15; 278 ( Pt 1):155-61. PMID: 1831973; PMCID: PMC1151462.
    146. Lin SH. Liver plasma membrane ecto-ATPase. Purification, localization, cloning, and functions. Ann N Y Acad Sci. 1990; 603:394-9; discussion 399-400. PMID: 2149809.
      View in: PubMed
    147. Lin SH. Localization of the ecto-ATPase (ecto-nucleotidase) in the rat hepatocyte plasma membrane. Implications for the functions of the ecto-ATPase. J Biol Chem. 1989 Aug 25; 264(24):14403-7. PMID: 2527234.
      View in: PubMed
    148. Lin SH, Guidotti G. Cloning and expression of a cDNA coding for a rat liver plasma membrane ecto-ATPase. The primary structure of the ecto-ATPase is similar to that of the human biliary glycoprotein I. J Biol Chem. 1989 Aug 25; 264(24):14408-14. PMID: 2527235.
      View in: PubMed
    149. Lin SH, Russell WE. Two Ca2+-dependent ATPases in rat liver plasma membrane. The previously purified (Ca2+-Mg2+)-ATPase is not a Ca2+-pump but an ecto-ATPase. J Biol Chem. 1988 Sep 5; 263(25):12253-8. PMID: 2457581.
      View in: PubMed
    150. Lin SH. The rat liver plasma membrane high affinity (Ca2+-Mg2+)-ATPase is not a calcium pump. Comparison with ATP-dependent calcium transporter. J Biol Chem. 1985 Sep 15; 260(20):10976-80. PMID: 3161886.
      View in: PubMed
    151. Lin SH. Novel ATP-dependent calcium transport component from rat liver plasma membranes. The transporter and the previously reported (Ca2+-Mg2+)-ATPase are different proteins. J Biol Chem. 1985 Jul 5; 260(13):7850-6. PMID: 2409077.
      View in: PubMed
    152. Lin SH, Fain JN. Purification of (Ca2+-Mg2+)-ATPase from rat liver plasma membranes. J Biol Chem. 1984 Mar 10; 259(5):3016-20. PMID: 6142050.
      View in: PubMed
    153. Lin SH, Fain JN. Ca2+-Mg2+-ATPase in rat hepatocyte plasma membranes: inhibition by vasopressin and purification of the enzyme. Prog Clin Biol Res. 1984; 168:25-30. PMID: 6151189.
      View in: PubMed
    154. Lin SH, Wallace MA, Fain JN. Regulation of Ca2+-Mg2+-ATPase activity in hepatocyte plasma membranes by vasopressin and phenylephrine. Endocrinology. 1983 Dec; 113(6):2268-75. PMID: 6139276.
      View in: PubMed
    155. Litosch I, Lin SH, Fain JN. Rapid changes in hepatocyte phosphoinositides induced by vasopressin. J Biol Chem. 1983 Nov 25; 258(22):13727-32. PMID: 6315708.
      View in: PubMed
    156. Fain JN, Lin SH, Litosch I, Wallace M. Hormonal regulation of phosphatidylinositol breakdown. Life Sci. 1983 May 2; 32(18):2055-67. PMID: 6302422.
      View in: PubMed
    157. Lin SH, Fain JN. Vasopressin and epinephrine stimulation of phosphatidylinositol breakdown in the plasma membrane of rat hepatocytes. Life Sci. 1981 Nov 2; 29(18):1905-12. PMID: 7311724.
      View in: PubMed
    158. Identification of bone-derived factors conferring de novo therapeutic resistance in metastatic prostate cancer. Cancer Research. 75:4949-4959.
    159. Intratumoral heterogeneity. Cancer.
    160. Radium-223. ONCOLOGY (United States). 29.
    161. Cadherin-11 endocytosis through binding to clathrin promotes cadherin-11-mediated migration in prostate cancer cells. Journal of Cell Science. 128:4629-4641.
    162. Mutational profiles reveal an aberrant TGF-β-CEA regulated pathway in colon adenomas. PLoS One. 11.
    163. Stem cells in carcinogenesis of the prostate. 73-79.
    164. RSK promotes prostate cancer progression in bone through ING3, CKAP2, and PTK6-mediated cell survival. Molecular Cancer Research. 13:348-357.
    165. Integrating murine and clinical trials with cabozantinib to understand roles of MET and VEGFR2 as targets for growth inhibition of prostate cancer. Clinical Cancer Research. 22:107-121.
    166. Intratumoral heterogeneity and chemoresistance in nonseminomatous germ cell tumor of the testis. Oncotarget. 7:86280-86289.
    167. Dynamic Phosphorylation of NudC by Aurora B in Cytokinesis. PLoS One. 11.
    168. Erratum to Metabolic Activation of CaMKII by Coenzyme A [(Molecular Cell, 52, (2013), 327-341]. Molecular Cell. 52:468.
    169. Yes-mediated phosphorylation of focal adhesion kinase at tyrosine 861 increases metastatic potential of prostate cancer cells. Oncotarget. 6:10175-10194.
    170. Phosphorylation-Dependent Activation of the ESCRT Function of ALIX in Cytokinetic Abscission and Retroviral Budding. Developmental Cell. 36:331-343.
    171. Plasma membrane isolation using immobilized concanavalin a magnetic beads. 29-41.
    172. C-CAM as target for gene therapy. Cancer Research Therapy and Control. 7:247-252.
    LIN's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description